You do know why this happens don't you? Bury the old negative refresh the shinny new. As a top 20 shareholder there's a lot on the line...
On a comparison of dealing with a FDA , crl another of my stocks just got a crl for minor labelling issues. The BOD put out the announcement after the trading halt, with a detailed power point, then arranged a webinar and took questions.
The problem with SPL is not the science but the BOD s treatment of SHs.
SPL Price at posting:
16.0¢ Sentiment: None Disclosure: Held
